LONDON In the coming weeks, a small, carefully selected group of volunteers is expected to arrive on the 11th floor of a London hospital to be given what the rest of the worlds 7.8 billion people have been trying to avoid: a coronavirus infection.
They will be administered tiny droplets of the virus into their nostrils as part of a plan authorized by British regulators on Wednesday to deliberately infect unvaccinated volunteers with the coronavirus.
The scientists hope to eventually expose vaccinated people to the virus as a way of comparing the effectiveness of different vaccines. But before that, the projects backers have to expose unvaccinated volunteers in order to determine the lowest dose of the virus that will reliably infect them.
By controlling the amount of the virus people are subjected to and monitoring them from the moment they are infected, scientists hope to discover things about how the immune system responds to the coronavirus that would be impossible outside a lab and to develop ways of directly comparing the efficacy of treatments and vaccines.
We are going to learn an awful lot about the immunology of the virus, Peter Openshaw, an Imperial College London professor involved in the study, said on Wednesday. He added that the study would be able to accelerate not only understanding of diseases caused by infection, but also to accelerate the discovery of new treatments and of vaccines.
The idea of such a study, called a human challenge trial, has been hotly debated since the early months of the pandemic.
In the past, scientists have deliberately exposed volunteers to diseases like typhoid and cholera to test vaccines. But infected people could be cured of those diseases; Covid-19 has no known cure, putting the scientists in charge of the British study in largely uncharted ethical territory.
To try to ensure that participants do not become seriously ill, the British study will be restricted to healthy volunteers in the 18 to 30 age range.
But there have been severe Covid-19 cases even in those types of patients, and the long-term consequences of an infection are also largely unknown. The age restrictions also may make it difficult to translate the findings to older adults or people with pre-existing conditions, whose immune responses might be different and who are the target group for treatments and vaccines.
It will be a limited study, said Ian Jones, a professor of virology at the University of Reading who is not part of the study. And you could argue that, by definition, its not going to study those in whom its most important to know whats going on.
For now, the only part of the study to be formally authorized by British regulators is the experiment to determine the lowest dose of virus needed to infect people.
After being exposed to the virus, the participants will be isolated for two weeks in the hospital. For that and the years worth of follow-up appointments that are planned, they will be paid 4,500 pounds, or about $6,200. The researchers said that would compensate people for time away from jobs or families without creating too large an economic incentive for people to participate.
Feb. 17, 2021, 10:09 p.m. ET
When the idea of human challenge trials was first floated last year, some scientists saw it as a way of shaving off crucial time in the race to identify a vaccine. Unlike in large clinical trials, in which scientists wait for vaccinated people to encounter the virus in their communities, researchers in this project would eventually purposely infect vaccinated people.
Now that several vaccines have been authorized, the goals of this human challenge trial are somewhat different.
For now, the researchers will expose people to the version of the virus that has been circulating in Britain since last spring, and not the more contagious and potentially deadlier variant that has taken hold more recently. But eventually, they said, they could give people experimental vaccines designed to address the effect of new, worrisome variants and then subject them to those versions of the virus.
They could also directly compare different vaccine doses and dosing intervals for the same vaccine.
And once the pandemic wanes and there are fewer hospitalized patients to enroll in drug trials, the scientists behind the study said that additional such trials where people are directly infected would allow them to continue investigating new treatments.
In the future, we wont have large numbers of people you can do studies on in the field, said Robert Read, a professor of infectious diseases at the University of Southampton, who helped design the study.
Infecting unvaccinated people with even low doses of the virus could yield important insights, said Andrew Catchpole, the chief scientific officer at hVIVO, a company specializing in human challenge trials that is involved in the study.
As intensely as the coronavirus has been studied, relatively little is understood about how peoples immune systems react in the immediate aftermath of being infected.
Nor do scientists yet know the specific type or level of immune responses that are necessary to completely protect most people from infection, a clue to how the dozens of vaccines that are still being studied will perform against the virus.
One of the things we dont understand is what is a truly protective response, said Lawrence Young, a virologist at Warwick Medical School, who is not involved in the study. Its a good way of understanding the host-pathogen interaction, though it does come with a whole heap of ethical issues, obviously.
In the first part of the study, the scientists will administer tiny doses of the virus to a small cohort of volunteers. If they do not become infected, the scientists will give slightly bigger doses to a different group of volunteers, repeating the process in up to 90 participants until they have determined the right dose.
By this spring, the scientists hope to repeat a version of their experiment by exposing vaccinated people to the virus. The British government, which is helping fund the study, will help choose the vaccines. Those and other future stages of the trial would require new regulatory approvals.
There has been no shortage of interest among potential volunteers in these types of trials, with thousands of people around the world registering their interest with 1Day Sooner, a group that advocates human challenge trials as a way of speeding the development of enough vaccines to inoculate people in parts of the world still waiting for doses
It is not clear how drug regulators in Britain or around the world would evaluate results from a human challenge trial, given the age restrictions and the small numbers of people involved.
But Dr. Catchpole said Britains drug regulator had indicated it would take any of the groups findings into consideration as it evaluates future vaccine candidates.
With the virus now acquiring dangerous mutations, one question facing the scientists is whether they will be able to keep up with its evolution.
Just as making new vaccines takes time, so does manufacturing new viral particles to infect people. Dr. Catchpole said that it would take the researchers three or four months to make a new coronavirus variant in a lab before they could begin putting droplets of it into the noses of volunteers.
Read the original post:
U.K. Approves Study That Will Infect Volunteers With Covid - The New York Times
- Why The Coronavirus Did Not Bring The Financial Rout That Many States Feared - The New York Times - March 2nd, 2021
- Florida coronavirus: State reports lowest case increase since October - WFLA - March 2nd, 2021
- See how sharply Ohio coronavirus cases, hospitalizations have dropped, and vaccines increased; county and sta - cleveland.com - March 2nd, 2021
- Coronavirus in Ohio Monday: COVID-19 vaccine eligibility expanded to those 60+ as more doses made available - NBC4 WCMH-TV - March 2nd, 2021
- 75 million coronavirus vaccine doses administered in the US - WBNG-TV - March 2nd, 2021
- Coronavirus Vaccine Woes & the Anniversary We Never Wanted: What Happened in San Diego in February 2021 - NBC San Diego - March 2nd, 2021
- G League looking into claim made by Jeremy Lin that he was called 'coronavirus' on court - ESPN - March 2nd, 2021
- The Latest: Thailand begins COVID-19 vaccinations - KTIV - February 28th, 2021
- Opinion | The Final Push to End the Coronavirus Pandemic in the U.S. - The New York Times - February 28th, 2021
- Can vaccinated people still spread the coronavirus? - The Conversation US - February 28th, 2021
- Coronavirus response | Wheels of justice to resume grinding in Champaign County - Champaign/Urbana News-Gazette - February 28th, 2021
- The Religion of the City: Cars, Mass Transit and Coronavirus - ArchDaily - February 28th, 2021
- The Coronavirus Is Plotting a Comeback. Heres Our Chance to Stop It for Good. - The New York Times - February 26th, 2021
- Timeline: One year of coronavirus in Rhode Island - The Providence Journal - February 26th, 2021
- New Findings on 2 Ways Children Become Seriously Ill From the Coronavirus - The New York Times - February 26th, 2021
- Ukraine records 50% spike in coronavirus cases - WBNG-TV - February 26th, 2021
- Ohio coronavirus alert map improves for first time in weeks; 4 counties downgraded from red alert to orange - cleveland.com - February 26th, 2021
- Coronavirus Roundup: Administration To Deliver Millions of Masks; Agencies Have Yet to Implement Many of Watchdog's Recommendations - GovExec.com - February 26th, 2021
- Steuben County reports 15 new cases of COVID-19, more than 5,500 confirmed since last year - WETM - MyTwinTiers.com - February 26th, 2021
- 105-Year Old Woman Survived Spanish Flu, and Now, Coronavirus - The New York Times - February 24th, 2021
- Dallas County reports 412 coronavirus cases and 18 deaths, including woman in her 30s without underlying - The Dallas Morning News - February 24th, 2021
- Coronavirus: NYC movie theaters to reopen with limited capacity in March - KIRO Seattle - February 24th, 2021
- Central Europe braced for third wave of coronavirus - Financial Times - February 24th, 2021
- Paid To Stay Home Coronavirus Aid Bill Pays Federal Employees With Kids Out Of School Up To $21K - Forbes - February 24th, 2021
- Coronavirus has stolen some kids' sense of smell, and it stinks - The Colorado Sun - February 24th, 2021
- Who's in the next coronavirus vaccine priority group in Louisiana? Higher education, clergy, more - The Advocate - February 24th, 2021
- Thailand to start first coronavirus vaccinations this week - Reuters - February 24th, 2021
- A Simple Rule of Thumb for Knowing When the Pandemic Is Over - The Atlantic - February 24th, 2021
- San Francisco has the lowest coronavirus case rate of major U.S. cities. But its schools are among the last to reopen - San Francisco Chronicle - February 22nd, 2021
- Positive Coronavirus Test? Canadians Worry Their Neighbors Will Find Out - The New York Times - February 22nd, 2021
- More than 20 cases of U.K. and South African COVID-19 variants found in South Carolina - WLTX.com - February 22nd, 2021
- How Will the Coronavirus Evolve? - Scientific American - February 20th, 2021
- COVID-19 surge is now helping to create herd immunity - Los Angeles Times - February 20th, 2021
- Tampa will have one of four FEMA coronavirus vaccination sites in Florida - Tampa Bay Times - February 20th, 2021
- Breath analyzer test deployed to help better screen coronavirus - University of Miami - February 20th, 2021
- Biden To Give $4 Billion To COVAX, Global COVID-19 Vaccine Effort - NPR - February 20th, 2021
- L.A. to expand mobile vaccination clinics in areas hardest hit by coronavirus - KTLA - February 20th, 2021
- True toll of coronavirus on sub-Saharan Africa may be obscured by tremendous variability in risk factors and surveillance - Princeton University - February 18th, 2021
- Red tier could be in sight as Orange County coronavirus metrics improve - Los Angeles Times - February 18th, 2021
- Coronavirus: Tourism thrives in Mexico against the odds - DW (English) - February 18th, 2021
- U.S.S. Theodore Roosevelt Has New Coronavirus Outbreak - The New York Times - February 18th, 2021
- Tracking COVID-19 in Alaska: 40 cases and 1 death reported Wednesday - Anchorage Daily News - February 18th, 2021
- Gwyneth Paltrow Reveals She Had COVID-19 Early on, and Shes Still Dealing With Symptoms - Prevention.com - February 18th, 2021
- W.H.O. Researcher Seeking Coronavirus Origins on His Trip to China - The New York Times - February 18th, 2021
- Garnar to hold weekly coronavirus briefing (Feb. 17) - WBNG-TV - February 18th, 2021
- Should I get the COVID-19 vaccine while breastfeeding? - WTOL - February 18th, 2021
- Sen. Sherrod Brown wants pension fix included in coronavirus relief bill - cleveland.com - February 18th, 2021
- Low coronavirus cases fuel hopes that organized sports will resume on Oahu - KHON2 - February 18th, 2021
- The coronavirus is here to stay here's what that means - Nature.com - February 16th, 2021
- Coronavirus in Michigan: Heres what to know Feb. 16, 2021 - WDIV ClickOnDetroit - February 16th, 2021
- Key Florida official overseeing COVID-19 response resigns - Wink News - Wink News - February 16th, 2021
- New Zealand On Alert As A Family Tests Positive For The Coronavirus : Coronavirus Updates - NPR - February 16th, 2021
- Covid-19 conspiracy theories and the superspreaders behind them - syracuse.com - February 16th, 2021
- 6 graphs to illustrate Ohio coronavirus trends for vaccines, hospitalizations, deaths and cases: mid-February - cleveland.com - February 16th, 2021
- Coronavirus will have lasting impact on restaurant industry - Food Safety News - February 16th, 2021
- New CDC school guidelines amid coronavirus: 4 key things to know - SILive.com - February 16th, 2021
- More than half of all COVID-19 cases in Michigan prisons are in Ionia County - Fox17 - February 16th, 2021
- Town of Secaucus - Corona Virus Information - February 14th, 2021
- Coronavirus in 3D, mutation origins and India invests in virology - Nature.com - February 14th, 2021
- Coronavirus Australia live news: Pfizer doses to arrive this week, Australia on track for vaccine rollout in late February - ABC News - February 14th, 2021
- 22 New Cases of Coronavirus UK Variant Found In CT: Heres Where - Patch.com - February 14th, 2021
- Health Care Workers Hit Hard by the Coronavirus Pandemic - The New York Times - February 14th, 2021
- Coronavirus: Latest developments in the Greater Toronto Area on Feb. 13 - Global News - February 14th, 2021
- Memphis surgeon dies of COVID-19 related illness weeks after receiving second vaccine - WAVY.com - February 14th, 2021
- Coronavirus in Michigan: Heres what to know Feb. 12, 2021 - WDIV ClickOnDetroit - February 12th, 2021
- CDC Says Double-Masking Offers More Protection Against The Coronavirus - NPR - February 12th, 2021
- Why all the world's coronavirus would fit in a can of cola - BBC News - February 12th, 2021
- Coronavirus Contextualized, 39th edition: Cases, hospitalizations continue to decrease though still double what they were in September - The Nevada... - February 12th, 2021
- How to schedule a COVID-19 vaccine at a Walmart in the Houston area - KHOU.com - February 12th, 2021
- Mathematician: All the COVID virus in the world could fit in a soda can - WFLA - February 12th, 2021
- Coronavirus takes its toll on state transportation fund - WKOW - February 12th, 2021
- Texas Gov. Greg Abbott considers relaxing COVID-19 business restrictions - The Texas Tribune - February 12th, 2021
- The Coronavirus Is a Master of Mixing Its Genome, Worrying Scientists - The New York Times - February 12th, 2021
- COVID: Using AstraZeneca vaccine is 'right thing to do' for everyone, says WHO expert panel - UN News - February 12th, 2021
- 5 things to know about the coronavirus today: Curfew ends, buffets open - dayton.com - February 12th, 2021
- Coronavirus by the numbers for Thursday, February 11 - WMBB - mypanhandle.com - February 12th, 2021
- COVID-19 Vaccines And Coronavirus Mutations : Shots - Health News - NPR - February 11th, 2021
- San Bernardino County using 89.5% of coronavirus vaccines within 4 days - San Bernardino County Sun - February 11th, 2021
- Coronavirus: Heineken to cut 8,000 jobs, move beyond beer to offset COVID-19 losses - KIRO Seattle - February 11th, 2021
- Massachusetts coronavirus vaccine buddy system will expand eligibility to people accompanying adults over 75 - Boston Herald - February 11th, 2021